Pharmaceutical Marketing

it’s been almost 15 years since U.S. direct-to-consumer advertising regulations were loosened. And in those years, the consumer pharmaceutical marketing industry has gone from about $700 million in ad spending to a peak of $5.4 billion in 2006. Spending in 2010 about $4.3 billion was down, but pharmaceutical advertising remains a big business. Before 1997, pharma marketers were allowed to name a brand in an ad but with the onus of the “brief summary,” a summation of side effects, contraindications and effectiveness usually written technically and typically anything but “brief.” Ads appeared in print, but the summary mandate would have made TV ads too long. FDA guidance, introduced in 1997 and formally adopted in 1999, allowed TV ads to name a pharma brand and the condition it treated without the summary. Instead, TV ads were required to include a “major statement” of the most important risks with a referral to a source of in-depth information. That led to the explosion of DTC advertising, mostly in TV.

Spotlight

Castle Creek Pharmaceuticals

Castle Creek Pharma is a high growth biopharmaceutical company founded by an experienced team of pharmaceutical entrepreneurs.

OTHER WHITEPAPERS
news image

Streamlining Distribution in the Pharmaceutical Industry

whitePaper | November 25, 2022

Satyendra Sinha is a Functional Consultant with the TCS Life Sciences unit, and focuses on order management, distribution.

Read More
news image

The Annual Clinical Trials Round-up 2021

whitePaper | October 13, 2022

In our previous edition of the Clinical Trials Roundup1, we explored the acute disruptions that the COVID-19 pandemic brought to the clinical trials landscape in 2020.

Read More
news image

Artificial Intelligence in Drug Manufacturing

whitePaper | May 25, 2023

CDER’s mission is to ensure that human drugs are safe and effective, meet established quality standards, and are available to patients. To advance this mission, FDA’s Pharmaceutical Quality for the 21st Century Initiative promotes an efficient, agile, and flexible pharmaceutical manufacturing sector that reliably produces quality drugs without excessive regulatory oversight.

Read More
news image

Four best practices for single-use supply chain success

whitePaper | February 16, 2023

Flexible and cost-effective, single-use technologies offer biopharmaceutical companies a way to transform their biologics production and meet the growing demand for these life-changing therapies.

Read More
news image

THE PHARMACEUTICAL INDUSTRY AND GLOBAL HEALTH

whitePaper | January 31, 2022

COVID-19 is an infectious disease caused by a newly discovered coronavirus, which was first identified in December 2019.

Read More
news image

WILL PHARMA COMMIT TO DELIVERING AFFORDABLE THERAPEUTICS AGAINST COVID-19?

whitePaper | April 8, 2020

EPHA is a change agent – Europe’s leading NGO alliance advocating for better health. We are a dynamic member-led organisation, made up of public health civil society, patient groups, health professionals, and disease groups working together to improve health and strengthen the voice of public health in Europe.

Read More

Spotlight

Castle Creek Pharmaceuticals

Castle Creek Pharma is a high growth biopharmaceutical company founded by an experienced team of pharmaceutical entrepreneurs.

Events